StockData
Braveheart Bio, Inc. logo

Braveheart Bio, Inc. (BRVE) stock

BRVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026
$20.39+1.12 (+5.81%)

Close on Nov 20, 2026Market cap $1.84BP/E –Yield –

Braveheart Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Braveheart Bio

Braveheart Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Braveheart Bio figures

See a number that looks wrong?